Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPTN
1626
DELISTED
SpartanNash
SPTN
| $14.7M | ﹤0.01% |
692,692
-4,076
| -0.6% | -$73.1K |
|
|
GBT
1627
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.7M | ﹤0.01% |
232,786
-49,461
| -18% | -$3.39M |
|
1628
STAAR Surgical
STAA
$1.3B
| $14.7M | ﹤0.01% |
238,511
+20,009
| +9% | +$817K |
|
1629
NMI Holdings
NMIH
$3.43B
| $14.6M | ﹤0.01% |
907,843
+137,246
| +18% | +$1.95M |
|
1630
AMC Global Media
AMCX
$505M
| $14.6M | ﹤0.01% |
622,352
-140,273
| -18% | -$3.68M |
|
1631
Schneider National
SNDR
$6.31B
| $14.5M | ﹤0.01% |
587,801
+100,863
| +21% | +$2.22M |
|
1632
Eagle Bancorp
EGBN
$875M
| $14.5M | ﹤0.01% |
442,160
-11,161
| -2% | -$356K |
|
1633
BOK Financial
BOKF
$8.88B
| $14.5M | ﹤0.01% |
256,049
-8,816
| -3% | -$451K |
|
|
SNR
1634
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $14.4M | ﹤0.01% |
3,991,543
+8,662
| +0.2% | +$26.1K |
|
1635
Ormat Technologies
ORA
$7.06B
| $14.4M | ﹤0.01% |
227,120
+6,538
| +3% | +$428K |
|
1636
Sea Limited
SE
$74.6B
| $14.4M | ﹤0.01% |
134,349
-10,888
| -7% | -$788K |
|
|
GRA
1637
DELISTED
W.R. Grace & Co.
GRA
| $14.4M | ﹤0.01% |
283,100
+19,375
| +7% | +$918K |
|
|
AAMI
1638
Acadian Asset Management
AAMI
$3.3B
| $14.4M | ﹤0.01% |
1,154,286
+296,644
| +35% | +$2.43M |
|
1639
Petrobras Class A
PBR.A
$104B
| $14.3M | ﹤0.01% |
1,796,165
-411,996
| -19% | -$2.89M |
|
|
ARNC
1640
DELISTED
Arconic Corporation
ARNC
| $14.3M | ﹤0.01% |
+1,026,013
| New | +$12M |
|
|
ONC
1641
BeOne Medicines Ltd
ONC
$39.3B
| $14.3M | ﹤0.01% |
75,734
+8,708
| +13% | +$1.42M |
|
1642
Enviri
NVRI
$576M
| $14.2M | ﹤0.01% |
1,050,071
+15,372
| +1% | +$154K |
|
|
OCFT
1643
DELISTED
OneConnect Financial Technology
OCFT
| $14.2M | ﹤0.01% |
77,660
+13,129
| +20% | +$1.76M |
|
1644
Voyager Therapeutics
VYGR
$201M
| $14.2M | ﹤0.01% |
1,122,435
+224,246
| +25% | +$2.61M |
|
1645
US Physical Therapy
USPH
$1.21B
| $14.2M | ﹤0.01% |
174,836
+12,225
| +8% | +$892K |
|
1646
AtriCure
ATRC
$2.26B
| $14.2M | ﹤0.01% |
314,988
-21,232
| -6% | -$924K |
|
1647
First Citizens BancShares
FCNCA
$25.8B
| $14.1M | ﹤0.01% |
34,836
-316
| -0.9% | -$116K |
|
1648
Spectrum Brands
SPB
$2.06B
| $14.1M | ﹤0.01% |
307,228
+83
| +0% | +$3.52K |
|
1649
Provident Financial Services
PFS
$3.21B
| $14M | ﹤0.01% |
971,762
-1,075
| -0.1% | -$14.4K |
|
1650
Virgin Galactic
SPCE
$498M
| $14M | ﹤0.01% |
42,871
+37,217
| +658% | +$12.2M |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.